An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims. Pharm Pract (Granada) [Internet]. 2012 Dec. 17 [cited 2025 Jan. 21];10(4):194-8. Available from: https://pharmacypractice.org/index.php/pp/article/view/3